Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2019 Nov 30

PMID 31781593

Citations 14

Authors

Jian Lv

Lili Li

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most common malignant tumors. The aim of the present study was to identify key genes and pathways to improve the understanding of the mechanism of CRC. GSE87211, including 203 CRC samples and 160 control samples, was screened to identify differentially expressed genes (DEGs). In total, 853 DEGs were obtained, including 363 upregulated genes and 490 downregulated genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of DEGs were performed to obtain enrichment datasets. GO analysis showed that DEGs were significantly enriched in the extracellular region, cell-cell signaling, hormone activity, and cytokine activity. KEGG pathway analysis revealed that the DEGs were mainly enriched in the cytokine-cytokine receptor interaction, drug metabolism, androgen and estrogen metabolism, and neuroactive ligand-receptor interaction. The Protein-Protein Interaction (PPI) network of DEGs was constructed by using Search Tool for the Retrieval of Interacting Genes (STRING). The app MCODE plugged in Cytoscape was used to explore the key modules involved in disease development. 43 key genes involved in the top two modules were identified. Six hub genes (CXCL, CXCL, PTGDR2, GRP, CXCL, and AGTR1) were statistically associated with patient overall survival or disease-free survival. The functions of six hub genes were mainly related to the hormone and chemokine activities. In conclusion, the present study may help understand the molecular mechanisms of CRC development.

Citing Articles

Effect of acute exercise on gene expression in peripheral blood mononuclear cells of puberty children.

Du L, Song Y, Tang L Sci Rep. 2024; 14(1):27977.

PMID: 39543149 PMC: 11564734. DOI: 10.1038/s41598-024-77242-8.

Advances in PGD2/PTGDR2 signaling pathway in tumors: A review.

Tian H, Ge K, Wang L, Gao P, Chen A, Wang F Biomol Biomed. 2024; 24(5):1055-1067.

PMID: 38704736 PMC: 11378995. DOI: 10.17305/bb.2024.10485.

Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.

Horaira M, Islam M, Kibria M, Alam M, Kabir S, Haque Mollah M BMC Med Genomics. 2023; 16(1):64.

PMID: 36991484 PMC: 10053149. DOI: 10.1186/s12920-023-01488-w.

Identification and verification of microRNA signature and key genes in the development of osteosarcoma with lung metastasis.

Meng F, Wang L, Gao G, Chen J, Wang X, Wu G Medicine (Baltimore). 2023; 101(49):e32258.

PMID: 36626488 PMC: 9750666. DOI: 10.1097/MD.0000000000032258.

Low Expression of AGPAT5 Is Associated With Clinical Stage and Poor Prognosis in Colorectal Cancer and Contributes to Tumour Progression.

Zang J, Sun J, Xiu W, Liu X, Chai Y, Zhou Y Clin Med Insights Oncol. 2022; 16:11795549221137399.

PMID: 36468151 PMC: 9716453. DOI: 10.1177/11795549221137399.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Zhang J, Bing Z, Yan P, Tian J, Shi X, Wang Y . Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma. J Gene Med. 2019; 21(8):e3105. DOI: 10.1002/jgm.3105. View

Javier Carmona F, Azuara D, Berenguer-Llergo A, Fernandez A, Biondo S, de Oca J . DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (Phila). 2013; 6(7):656-65. DOI: 10.1158/1940-6207.CAPR-12-0501. View

Radnai B, Sturm E, Stancic A, Jandl K, Labocha S, Ferreiros N . Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease. J Crohns Colitis. 2016; 10(9):1087-95. PMC: 4892354. DOI: 10.1093/ecco-jcc/jjw061. View

Chen M, Baskaran R, Lee N, Hsu H, Ho T, Tu C . CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11. J Cell Physiol. 2018; 234(7):11822-11834. DOI: 10.1002/jcp.27891. View

Hu Y, Gaedcke J, Emons G, Beissbarth T, Grade M, Jo P . Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery. Genes Chromosomes Cancer. 2017; 57(3):140-149. PMC: 5778444. DOI: 10.1002/gcc.22512. View

Westwood D, Patel O, Christophi C, Shulkes A, Baldwin G . Progastrin: a potential predictive marker of liver metastasis in colorectal cancer. Int J Colorectal Dis. 2017; 32(7):1061-1064. DOI: 10.1007/s00384-017-2822-8. View

Wang P, Yang X, Xu W, Li K, Chu Y, Xiong S . Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy. Cancer Immunol Immunother. 2010; 59(11):1715-26. PMC: 11030099. DOI: 10.1007/s00262-010-0901-6. View

Ma Y, Xia Z, Ye C, Lu C, Zhou S, Pan J . AGTR1 promotes lymph node metastasis in breast cancer by upregulating CXCR4/SDF-1α and inducing cell migration and invasion. Aging (Albany NY). 2019; 11(12):3969-3992. PMC: 6628987. DOI: 10.18632/aging.102032. View

10.

He X, Zhang J . Why do hubs tend to be essential in protein networks?. PLoS Genet. 2006; 2(6):e88. PMC: 1473040. DOI: 10.1371/journal.pgen.0020088. View

11.

Chen R, Hong Q, Jiang J, Chen X, Jiang Z, Wang J . promoter hypermethylation in lung squamous cell carcinoma but not in lung adenocarcinoma. Oncol Lett. 2017; 14(4):4989-4994. PMC: 5649578. DOI: 10.3892/ol.2017.6824. View

12.

Tokunaga R, Zhang W, Naseem M, Puccini A, Berger M, Soni S . CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2017; 63:40-47. PMC: 5801162. DOI: 10.1016/j.ctrv.2017.11.007. View

13.

Voorneveld P, Reimers M, Bastiaannet E, Jacobs R, van Eijk R, Zanders M . Statin Use After Diagnosis of Colon Cancer and Patient Survival. Gastroenterology. 2017; 153(2):470-479.e4. DOI: 10.1053/j.gastro.2017.05.011. View

14.

Ferrand A, Sandrin M, Shulkes A, Baldwin G . Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth. Biochim Biophys Acta. 2009; 1793(3):477-88. PMC: 2692632. DOI: 10.1016/j.bbamcr.2009.01.004. View

15.

Xin H, Cao Y, Shao M, Zhang W, Zhang C, Wang J . Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. Int Urol Nephrol. 2018; 50(5):861-868. DOI: 10.1007/s11255-018-1818-9. View

16.

Narayanankutty A . PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence. Curr Drug Targets. 2019; 20(12):1217-1226. DOI: 10.2174/1389450120666190618123846. View

17.

Liu W, Liu Y, Fu Q, Zhou L, Chang Y, Xu L . Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma. Oncotarget. 2016; 7(12):13976-83. PMC: 4924692. DOI: 10.18632/oncotarget.7468. View

18.

Balkwill F . Cancer and the chemokine network. Nat Rev Cancer. 2004; 4(7):540-50. DOI: 10.1038/nrc1388. View

19.

Hu Y, Zhang Y, Ren J, Wang Y, Wang Z, Zhang J . Statistical Approaches for the Construction and Interpretation of Human Protein-Protein Interaction Network. Biomed Res Int. 2016; 2016:5313050. PMC: 5015007. DOI: 10.1155/2016/5313050. View

20.

Liu B, Huang G, Cheng H . Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer. J Comput Biol. 2019; 26(11):1262-1277. DOI: 10.1089/cmb.2019.0073. View